Mycobacterium vaccae (SRL172) immunotherapy as an adjunct to standard antituberculosis treatment in HIV-infected adults with pulmonary tuberculosis: a randomised placebo-controlled trial.
about
Mycobacterium vaccae as adjuvant therapy to anti-tuberculosis chemotherapy in never-treated tuberculosis patients: a meta-analysisRandomized, placebo-controlled phase II trial of heat-killed Mycobacterium vaccae (Longcom batch) formulated as an oral pill (V7)Randomized, placebo-controlled Phase II trial of heat-killed Mycobacterium vaccae (Immodulon batch) formulated as an oral pill (V7)The TB pandemic: an old problem seeking new solutions.The immunology of tuberculosis: from bench to bedside.HIV: treating tuberculosis.Safety and immunogenicity of H1/IC31®, an adjuvanted TB subunit vaccine, in HIV-infected adults with CD4+ lymphocyte counts greater than 350 cells/mm3: a phase II, multi-centre, double-blind, randomized, placebo-controlled trial.Immunotherapeutic role of Ag85B as an adjunct to antituberculous chemotherapyWhat has Karonga taught us? Tuberculosis studied over three decades.Epidemiology of Respiratory Disease in Malawi.Tuberculosis vaccines: current status and future prospects.Therapeutic vaccination to treat chronic infectious diseases: current clinical developments using MVA-based vaccines.Role of co-trimoxazole prophylaxis in reducing mortality in HIV infected adults being treated for tuberculosis: randomised clinical trial.Immunoregulation in TB: observations and implicationsThe potential of immunomodulatory drugs in the treatment of solid tumors.Tuberculosis vaccines in clinical trials.Immunity to TB and targets for immunotherapy.Adjunct immunotherapies for tuberculosis.Shortening the 'short-course' therapy- insights into host immunity may contribute to new treatment strategies for tuberculosis.Efficacy of Mycobacterium vaccae immunotherapy for patients with tuberculosis: A systematic review and meta-analysis.Immunotherapy for tuberculosis: wave of the future or tilting at windmills?Recent developments in tuberculosis vaccines
P2860
Q21135251-97A19358-D93E-4CDE-BA1A-8F5A9D931C42Q28293125-337A5002-C935-475B-859D-BA571A041CEBQ28299689-7040F40C-BE78-4E5D-AF47-00B4EE4D990FQ30360726-2D082C81-C18A-441D-818C-C658151D70A1Q33777367-039F54FB-C535-4EAA-8038-481875C7ED8EQ33950001-31AA2372-7E18-4F17-AD83-B9D5C8DA4001Q34663035-E9799523-66E7-42C6-9819-9CFC5A5074CEQ35124651-01B6659B-FAEB-45D4-9460-C6A4D9536C9CQ35737870-B530D44E-53C7-47D7-9DBE-20CFD8EDEB03Q35937990-3B831B3E-8A19-4A59-8D6A-E98406C241B5Q36458393-A4D4F8E4-DCC0-4395-987A-661C9ABD54F1Q36849770-9D7A9857-0143-4550-9C70-1DF1A72FB127Q37131431-E6528F13-EBC7-4DD8-BFB7-54E6606FFD9DQ37742701-E990136F-37A3-4A96-857F-48967BCB36DFQ37797475-A493B0EB-42A0-45C5-AA1C-999670315A1EQ37878483-67CCE39F-E988-4CC3-84C2-DE90D3E0A672Q37984571-201A184E-35F0-418B-AEA0-653D0000CE49Q37998000-7C1CF8CD-5C2B-497D-9B2A-E7179F6D3D2AQ38075095-47807261-1C31-4569-997B-0604DCEBF919Q39366210-7141AF70-2B9C-4C8F-989C-68E0CAE8C8C8Q53924348-820D5CEF-A2CE-48E0-B587-DC516FAD40B1Q58834925-AEEFB076-DE18-499C-B2D3-7743AEA5AA02
P2860
Mycobacterium vaccae (SRL172) immunotherapy as an adjunct to standard antituberculosis treatment in HIV-infected adults with pulmonary tuberculosis: a randomised placebo-controlled trial.
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Mycobacterium vaccae (SRL172) ...... ised placebo-controlled trial.
@ast
Mycobacterium vaccae (SRL172) ...... ised placebo-controlled trial.
@en
Mycobacterium vaccae
@nl
type
label
Mycobacterium vaccae (SRL172) ...... ised placebo-controlled trial.
@ast
Mycobacterium vaccae (SRL172) ...... ised placebo-controlled trial.
@en
Mycobacterium vaccae
@nl
prefLabel
Mycobacterium vaccae (SRL172) ...... ised placebo-controlled trial.
@ast
Mycobacterium vaccae (SRL172) ...... ised placebo-controlled trial.
@en
Mycobacterium vaccae
@nl
P2093
P50
P921
P1433
P1476
Mycobacterium vaccae (SRL172) ...... mised placebo-controlled trial
@en
P2093
Alwyn Mwinga
Chifumbe Chintu
David Warndorff
Janet Darbyshire
LUSKAR collaboration
P304
P356
10.1016/S0140-6736(02)11141-X
P407
P577
2002-10-01T00:00:00Z